GlassScriptPhysician profile
Patricia Lien
NPI 1417388596
$1,286.58
in general payments reported to CMS, 2019-2025
21 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.98 · 2022: $117 · 2023: $398 · 2024: $270 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $213.03 | 2022-2025 | |
| Depuy Synthes Sales INC. | $118.21 | 2022-2025 | Monovisc, Orthovisc |
| Forte Bio-Pharma LLC | $107.35 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $90.82 | 2023-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $90.19 | 2021-2025 | General - Pain Management, Intracept |
| Astrazeneca Pharmaceuticals LP | $88.64 | 2023 | Tezspire |
| Biotronik Nro, INC. | $85.68 | 2024-2025 | Prospera |
| Novo Nordisk INC | $71.43 | 2023 | Wegovy |
| Merz Pharmaceuticals, LLC | $68.79 | 2024-2025 | Xeomin |
| Tersera Therapeutics LLC | $62.91 | 2025 | Prialt |
| Si-Bone, INC. | $57.61 | 2023-2025 | |
| Abbott Laboratories | $42.04 | 2022-2024 | Eterna |
| Azurity Pharmaceuticals, INC. | $34.89 | 2023-2024 | Horizant, Horizant |
| Kowa Pharmaceuticals America, INC. | $27.30 | 2023 | Seglentis |
| Nalu Medical, INC. | $22.51 | 2024 | Nalu Neurostimulation System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $20.91 | 2023 | Sprint Pns System |
| Medtronic, INC. | $20.40 | 2024 | Intellis Adaptivestim |
| Ferring Pharmaceuticals INC. | $18.75 | 2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $17.88 | 2022 | |
| Microtransponder, INC. | $13.94 | 2025 | |
| Arbor Pharmaceuticals, INC. | $13.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Lien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.